Home/ Stocks/ RDHL

Redhill Biopharma Ltd.

RDHL XNAS

$1.03 +0.38 (+57.29%) ▲ 15-min delayed

Open

$1.36

High

$1.60

Low

$1.01

Volume

92.09M

Market Cap

$4.02M

About Redhill Biopharma Ltd.

RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.

Employees: 23 Website →

TickerDaily Coverage

Why Is Redhill Biopharma (RDHL) Stock Up 139.0% Today?

Penny Stocks Marcus Rivera · 2h ago

Redhill Biopharma (RDHL) exploded 139% on Monday, August 31, 2026, after receiving a Nasdaq staff...

View All Coverage →

Get RDHL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Redhill Biopharma Ltd..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.